Mitral Regurgitation Clinical Trials in Houston, Texas

6 studies are recruiting for mitral regurgitation in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Cephea Early Feasibility Study

   The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Houston Methodist, Houston, Texas

   Locations

   22 in total

   Run by

   Abbott Medical Devices

   See if you can join NCT05061004 on ClinicalTrials.gov

2. Abbott Cephea Mitral Valve Disease Registry

   The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of co…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Houston Methodist, Houston, Texas

   Locations

   24 in total

   Run by

   Abbott Medical Devices

   See if you can join NCT07069673 on ClinicalTrials.gov

3. ATLAS (AltaValve) Pivotal Trial

   This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.

   Stage

   Not phased

   Ages

   18 and older

   Site

   The University of Texas Health Science Center at Houston, Houston, Texas

   Locations

   58 in total

   Run by

   4C Medical Technologies, Inc.

   See if you can join NCT06465745 on ClinicalTrials.gov

4. CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry

   This multinational, investigator-initiated registry aims to investigate clinical outcomes of patients undergoing transcatheter mitral valve replacement (TMVR). The registry primarily focuses on patients treated with TMVR in real-world clinical practice. Patients evaluated for TMVR but not undergoin…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Houston Methodist Hospital, Houston, Texas

   Locations

   43 in total

   Run by

   Universitätsklinikum Hamburg-Eppendorf

   See if you can join NCT04688190 on ClinicalTrials.gov

5. The ENCIRCLE Trial

   This study will establish the safety and effectiveness of the SAPIEN M3 System in subjects with symptomatic, at least 3+ mitral regurgitation (MR) for whom commercially available surgical or transcatheter treatment options are deemed unsuitable. Following completion of enrollment, subjects will be …

   Stage

   Not phased

   Ages

   18 and older

   Site

   HCA Houston Healthcare Medical (SCRI), Houston, Texas

   Locations

   68 in total

   Run by

   Edwards Lifesciences

   See if you can join NCT04153292 on ClinicalTrials.gov

6. An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System

   Study to evaluate the feasibility, safety and performance of the HighLife trans-septal Transcatheter Mitral Valve in patients with moderate-severe and severe mitral regurgitation who are at high risk for surgical treatment.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Houston Methodist Hospital, Houston, Texas

   Locations

   10 in total

   Run by

   HighLife SAS

   See if you can join NCT04029337 on ClinicalTrials.gov